论文部分内容阅读
肝癌的介入治疗即经股动脉插管行肝动脉灌注化疗栓塞(TACE),现已成为不能切除的肝癌非手术治疗患者的首选方法[1]。胸腔积液是介入术后的并发症之一。了解其发病原因,对预防和治疗并发的胸腔积液有重要意义。本文对我院肝癌介入治疗术后出现胸腔积液的患者进行分析,现报道如下
Interventional treatment of liver cancer through the femoral artery catheterization of transcatheter arterial chemoembolization (TACE), has now become the first choice of non-surgical treatment of patients with unresectable liver cancer [1]. Pleural effusion is one of the complications after interventional surgery. To understand its causes, prevention and treatment of concurrent pleural effusion is important. This article on our hospital liver cancer after interventional treatment of patients with pleural effusion were reported as follows